These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Migraine prophylaxis: what is new and what we need? Barbanti P; Aurilia C; Egeo G; Fofi L Neurol Sci; 2011 May; 32 Suppl 1():S111-5. PubMed ID: 21533725 [TBL] [Abstract][Full Text] [Related]
14. New and emerging prophylactic agents for migraine. Krymchantowski AV; Bigal ME; Moreira PF CNS Drugs; 2002; 16(9):611-34. PubMed ID: 12153333 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A and acute drug costs in migraine with triptan overuse. Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of topiramate in migraine prophylaxis: an open controlled randomized study comparing Sincronil and topamax formulations. Cosentino G; Paladino P; Maccora S; Indovino S; Fierro B; Brighina F Panminerva Med; 2013 Sep; 55(3):303-7. PubMed ID: 24088805 [TBL] [Abstract][Full Text] [Related]
17. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J; Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844 [TBL] [Abstract][Full Text] [Related]
18. Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives NJ; Clarke CE; Sinclair AJ BMJ Open; 2019 Jul; 9(7):e027953. PubMed ID: 31315864 [TBL] [Abstract][Full Text] [Related]